Cargando…

Sequential C-reactive protein measurements in patients with serious infections: does it help?

C-reactive protein (CRP) is a marker of inflammation traditionally used as a complementary tool to support the clinical diagnosis and as a marker of severity of disease. CRP is an acute-phase protein synthesized by the liver after stimulus by cytokines and its serum levels increase markedly within h...

Descripción completa

Detalles Bibliográficos
Autor principal: Lobo, Suzana M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580631/
https://www.ncbi.nlm.nih.gov/pubmed/22731851
http://dx.doi.org/10.1186/CC11347
_version_ 1782260294469287936
author Lobo, Suzana M
author_facet Lobo, Suzana M
author_sort Lobo, Suzana M
collection PubMed
description C-reactive protein (CRP) is a marker of inflammation traditionally used as a complementary tool to support the clinical diagnosis and as a marker of severity of disease. CRP is an acute-phase protein synthesized by the liver after stimulus by cytokines and its serum levels increase markedly within hours after the onset of infection, inflammation or tissue injury. Dynamic serial measurement of CRP has been widely used to help therapeutic decision-making. Decreasing plasma concentrations of this biomarker have been used as an indicator for resolution of infection or sepsis.
format Online
Article
Text
id pubmed-3580631
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35806312013-06-18 Sequential C-reactive protein measurements in patients with serious infections: does it help? Lobo, Suzana M Crit Care Commentary C-reactive protein (CRP) is a marker of inflammation traditionally used as a complementary tool to support the clinical diagnosis and as a marker of severity of disease. CRP is an acute-phase protein synthesized by the liver after stimulus by cytokines and its serum levels increase markedly within hours after the onset of infection, inflammation or tissue injury. Dynamic serial measurement of CRP has been widely used to help therapeutic decision-making. Decreasing plasma concentrations of this biomarker have been used as an indicator for resolution of infection or sepsis. BioMed Central 2012 2012-06-18 /pmc/articles/PMC3580631/ /pubmed/22731851 http://dx.doi.org/10.1186/CC11347 Text en Copyright ©2012 BioMed Central Ltd
spellingShingle Commentary
Lobo, Suzana M
Sequential C-reactive protein measurements in patients with serious infections: does it help?
title Sequential C-reactive protein measurements in patients with serious infections: does it help?
title_full Sequential C-reactive protein measurements in patients with serious infections: does it help?
title_fullStr Sequential C-reactive protein measurements in patients with serious infections: does it help?
title_full_unstemmed Sequential C-reactive protein measurements in patients with serious infections: does it help?
title_short Sequential C-reactive protein measurements in patients with serious infections: does it help?
title_sort sequential c-reactive protein measurements in patients with serious infections: does it help?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580631/
https://www.ncbi.nlm.nih.gov/pubmed/22731851
http://dx.doi.org/10.1186/CC11347
work_keys_str_mv AT lobosuzanam sequentialcreactiveproteinmeasurementsinpatientswithseriousinfectionsdoesithelp